. . . . . . . . . . . . . . . . . . . . . "a(SCHEM:\"Phosphatidylinositol-3,4,5-trisphosphate\") -> (kin(p(HGNC:INSR)) -> p(HGNC:DAPP1,pmod(P,Y,139)))" . "kin(p(HGNC:INSR)) -> p(HGNC:DAPP1,pmod(P,Y,139))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Treatment of cells with phosphoinositide 3-kinase (PI 3-kinase) inhibitors or expression of a dominant-negative PI 3-kinase prevent phosphorylation of DAPP1 at Tyr(139), and a PH-domain mutant of DAPP1, which does not interact with PtdIns(3,4,5)P(3) or PtdIns(3,4)P(2), is not phosphorylated at Tyr(139) following agonist stimulation of cells." . . "Selventa" . . . . "2014-07-03T14:29:51.497+02:00"^^ . . .